- Research article
- Open Access
Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey
BMC Public Health volume 16, Article number: 1112 (2016)
The seroprevalence of human cytomegalovirus (HCMV) infection ranges from 30 to 90 % in developed countries. Reliable estimates of HCMV seroprevalence are not available for Pakistan. This study determined the seroprevalence and sociodemographic factors associated with HCMV infection in adult populations of Karachi, Pakistan.
A seroprevalence survey was conducted on 1000 adults, including residents of two semi-urban communities, and visitors to a government and a private hospital. Questionnaire-based interviews were conducted. Sera were analysed for HCMV-specific IgG and IgM. Chi-square or Fisher’s exact test was used for comparing sociodemographic variables against seropositivity of HCMV-IgG or IgM. Multiple logistic regression modeling was performed for IgG seroprevalence and adjusted odds ratios were computed.
The seroprevalence of HCMV-IgG and IgM was 93.2 and 4.3 % respectively. 95.3 % of individuals who were IgM seropositive were also seropositive for IgG. Around 6 % (15/250) of women of childbearing age remained uninfected and were therefore susceptible to primary infection. HCMV-IgG seroprevalence was associated with being female (p = 0.001), increasing age (p = 0.002) and crowding index (p = 0.003) and also with lower levels of both education (p < 0.001) and income (p = 0.008). Seroprevalence also differed significantly by marital status (p = 0.008) and sampling location (p < 0.001). A logistic regression model for HCMV-IgG seroprevalence showed associations with being female (OR = 1.89; 95 % CI: 1.10–3.25), increasing age (OR = 3.95; 95 % CI: 1.79–8.71) and decreasing income (OR = 0.72; 95 % CI: 0.54–0.96). A strong association was observed between increased seroprevalence of HCMV-IgM and decreasing household size (p = 0.008).
Seroprevalence of HCMV is very high in Pakistan, although 6 % of women of childbearing age remain at risk of primary infection. The IgM seropositivity observed in some individuals living in small household size (1–3 individuals) with persistent HCMV infection could have resulted from a recurrent HCMV infection. Future longitudinal research in pregnant women and neonates is required to study the trends in HCMV seroprevalence over time in Pakistan for the development of a potential HCMV prevention and vaccination programme.
Human cytomegalovirus (HCMV) is a member of the Herpesviridae family, and the virus may be shed intermittently in bodily fluids (saliva, urine, semen, blood and breast milk) . As such, its transmission occurs both horizontally and vertically through close contact and directly from mother to embryo, fetus, or baby . Upon primary infection, which is usually asymptomatic , HCMV establishes a state of lifelong latency, during which infectious virus is difficult to isolate . Active HCMV infection can result from primary infection in a previously seronegative individual or reactivation in a seropositive individual  in response to immunosuppression and inflammation . Viral reactivation is associated with significant morbidity and mortality in immunocompromised individuals, such as patients with HIV infection or those undergoing solid organ or bone marrow transplantation, and up to 15 % of babies who acquire congenital infection, manifest signs of cytomegalic inclusion disease (CID) at birth .
Seroprevalence of HCMV varies from 30 to 90 % in most developed countries  and the seroprevalence is dependent on sociodemographic factors . Adult populations in Africa , Asia [9–11] and South America [12, 13] have higher HCMV seroprevalence than European [14–16] and North American populations . In addition, seroprevalence is reported with increasing age  and an inverse correlation with socioeconomic status [17, 18].
Most HCMV seroepidemiological studies have previously focused on children and women of childbearing age, as they constitute groups at highest risk of developing HCMV infection [19, 20]. Studies determining seroprevalence of HCMV-IgG antibodies in the general population are predominantly limited to developed countries that have assessed the impact of sociodemographic factors on HCMV-IgG seropositivity [7, 18]. Similar research in developing countries are lacking in terms of sample size and in depth analysis of sociodemographic data [9, 12]. Moreover, the sociodemographic characteristics of HCMV-IgM seroprevalence have not been widely explored both in developed and developing countries.
At the current time, there is minimal information regarding the epidemiological determinants of HCMV infection in Pakistan . We undertook a study to determine the seroprevalence of HCMV-specific IgG and IgM antibodies and also to identify the sociodemographic factors associated with HCMV-IgG and HCMV-IgM seropositivity in adult populations of Karachi, Pakistan.
Study design and locations
We conducted a seroprevalence survey during the period from July 2010 to June 2012 in adult populations of Karachi, Pakistan. Study locations comprised of two major hospitals and two medical camps held in two semi-urban communities. The hospital location comprised of gastroenterology sections of two major tertiary care government and private hospitals, namely, Jinnah Postgraduate Medical Centre (JPMC) and Aga Khan University Hospital (AKUH) respectively. The Department of Gastroenterology and Hepatology unit at JPMC serves as a screening centre for patients from across Pakistan suspected of being infected with hepatitis B or C. The section of gastroenterology at AKUH provides high quality standard care for liver and pancreato-biliary diseases and also serves as a referral centre for interventional procedures to treat gastrointestinal ailments. Visitors to JPMC are predominantly from a lower socioeconomic class whilst most patients attending AKUH are of middle to high socioeconomic status.
Karachi is a metropolitan city with six districts, divided into 18 towns . It has a multi-ethnic and multi-lingual population, majority being Sindhi and Urdu speaking. Two semi-urban communities, namely, Jam Goth and Radho Jokhio Goth were selected from Malir town and Gadap town respectively, located in Malir district, Karachi. Area wise, Gadap town is larger than Malir town, the latter being more densely populated. Gadap town is amongst the least developed areas of Karachi whilst Malir town is relatively more developed. Both towns are inhabited by ethnically diverse communities.
Study population and sampling
All consenting males and females (N = 1000) aged 18 years or older at the time of enrolment were included in this study. The study population comprised of patients visiting the gastroenterology sections of JPMC and AKUH, and people residing in two semi-urban communities; and for analysis purpose identified as community A (Malir town) and community B (Gadap town). The sample size estimate was based on the assumption that approximately 80 % of the population would be seropositive for HCMV . An alpha level of 0.05, margin of error of 3.5 %, and design effect of 2 was used for sample size calculation.
Participants from the two towns were approached after consultation, discussion, engagement and agreement of community leaders with whom the aims of our study were explained. In all sampling locations, a convenient sampling technique was employed to select the study participants. The study objectives were explained to the study participants in the simplest possible manner to satisfy the understanding of the respondents. A blood sample was collected and a questionnaire-based interview was conducted with all consenting participants.
Questionnaire and data collection
The questionnaire-based interviews were designed to obtain personal and sociodemographic information of the participants. The contents of the questionnaire were in compliance with previous studies conducted to determine associated factors of HCMV infection [7, 17]. The questionnaire was developed in English and translated into Urdu (the national language of Pakistan). The English and Urdu versions were pre-tested by conducting in-person interviews of the staff at the AKUH and residents of community A respectively and both versions were modified accordingly.
The sociodemographic characteristics of the participants were assessed by a set of variables, namely, age (years), gender, marital status (married/unmarried/divorced/widowed/separated), ethnicity defined by mother tongue (Sindhi/Baloch/Punjabi/Pakhtoon/Urdu speaking/Other), education level (years of school attended), house construction material (straw or wood or mud/mix of mud and concrete bricks/concrete bricks only), monthly household income was asked in local currency of Rupees, and for analysis purpose was converted as equivalent to U.S. dollars (USD), number of rooms in the house and household (HH) size that was defined as total number of people living together in the same house; the last two variables were used as indicators of crowding to create a new variable ‘crowding index’ (total number of residents per household divided by the total number of rooms in house). Continuous variables for age, income, household size and crowding index when categorised were done using quartiles. Some variables were categorised into two categories if sparse data were available, for example, few participants were either divorced, widowed or separated, then the marital status was grouped into two categories of married and unmarried.
Samples of up to five ml of blood were collected in serum separation tubes (BD Biosciences, San Jose, CA, USA). Serum was separated and analysed for the presence of HCMV-IgG or IgM in duplicate using commercial enzyme immunoassay kits (BioCheck Inc, Foster City, CA, USA). Absorbance was recorded at 450 nm within 15 min on a Chameleon Microplate Reader (Hidex, Turku, Finland). Positive and negative results of the assays were determined according to the manufacturer’s specifications.
Data entry and statistical analysis were performed using SPSS version 19.0 (IBM Corporation, Chicago, IL, USA). Continuous variables were checked for normal distribution and log transformation was attempted to improve the distribution and when necessary were categorised according to median and quartiles. The outcome variables were the positive or negative sero-status of HCMV-IgG and IgM. Cross tabulations were performed against the sociodemographic variables. Chi-square or Fisher’s exact test was used as a statistical test of significance for comparing sociodemographic variables against seropositivity of HCMV-IgG or IgM. A p value of < 0.05 from two-tailed tests was considered significant in all tests. Odds ratios (OR) and 95 % confidence intervals (CI) were calculated for the relationships between sociodemographic variables and seropositive status for HCMV-IgG or IgM. Multiple logistic regression modeling was performed for IgG seroprevalence and adjusted ORs were computed.
Of the 1000 participants, 63.4 % were enrolled at the government hospital and nearly 14.9 % at the private hospital whilst 3.6 % in community A and 18.1 % in community B were recruited. The study group comprised of 46.3 % males and 53.7 % females with a mean age of 36 years (standard deviation [SD] = 12.6). The mean age of males and females was 35.3 years (SD = 13) and 36.6 years (SD = 12.3) respectively. There were more than six ethnic groups; Sindhi (30.1 %), Baloch (9.9 %), Punjabi (11.9 %), Pakhtoon (14.1 %), Urdu speaking (19.9 %), and ‘Other’ (14.1 %). Overall, 36.8 % of the participants were not literate whilst 13.8, 23.7 and 25.7 % reported 1-6, 7-10 and > 10 years of education respectively. The majority of participants (66.6 %) lived in concrete houses compared with 33.4 % inhabiting houses made of straw/wood/mud or mix of mud and concrete. Only 9.1 % of individuals lived in houses with ≤ 3 persons per household. The distribution of household crowding index of participants was ≤ 2 (28.9 %), > 2-3 (20.9 %), > 3-5 (27.5 %), and > 5 (22.7 %). Monthly income varied from ≤ USD 70 in 30.6 %, USD 71–100 in 21.1 %, USD 101–200 in 25.3 %, and > USD 200 in 23 % (Table 1).
The seroprevalence of HCMV-IgG was 93.2 % (95 % confidence interval [CI]: 91.5–94.6). The seroprevalence of IgG differed by sampling location, as there were 83.9 % (125/149) from private hospital visitors, 95 % (602/634) from government hospital visitors, 86.1 % (31/36) from community A residents, and 96.1 % (174/181) from community B residents. Using private hospital as reference, government hospital and community B participants had greater odds of being IgG positive. Similarly, females and married persons had greater odds of being IgG positive than males and unmarried persons respectively. Older age groups had higher prevalence of IgG and younger age groups displayed more IgG seronegativity (Table 1). Over 80 % of males and females were already infected with HCMV by the age of ≤ 25 years. However, seroprevalence varied by a 10 % difference between males (84.6 %) and females (94.4 %) in this age group. Seroprevalence in females remained consistently high during ageing and peaked at over 97 %. Within men, seroprevalence increased from 84.6 % (<25 years) to 96.4 % (35–45 years) with age. Around 6 % (15/250) of women aged < 35 years, considered to be prime child bearing age in Pakistan, remained IgG seronegative when primary infection within men of corresponding age was 219/252 (86.9 %). As such, 10 % of men underwent viral seroconversion over a 20 year period, indicating a rate of primary infection of around 0.5 % per year (Fig. 1). An individual’s level of education had a significant effect on the odds of being IgG positive, with up to 6 years of education increasing the odds four times. Lower levels of monthly income had greater odds of being associated with higher IgG seroprevalence compared to highest level of monthly income. Increased crowding index was associated with greater odds of having IgG positive test (Table 1).
The overall seroprevalence of IgM was 4.3 % (43/1000, 95 % CI: 3.2–5.7 %). Forty one individuals (41/1000, 4.1 %) were HCMV-IgM and HCMV-IgG seropositive, whilst only 2 (2/1000, 0.2 %) were HCMV-IgM seropositive and HCMV-IgG seronegative. 95.3 % (41/43) of individuals who were IgM seropositive were also seropositive for IgG. Sixty six samples (6.6 %) were found to be seronegative for HCMV. Smaller household size for number of persons was strongly associated with a higher seroprevalence of IgM (p = 0.008). Using reference of HH size of > 10 persons, HH size of 1–3 persons had 23.3 % as IgM positive compared to 8.4 % IgM negative (OR = 4.58 95 % CI: 1.47–14.72); HH size of 4–6 persons had 25.6 % as IgM positive compared to 31.5 % IgM negative (OR = 1.35 95 % CI: 0.45–4.18); HH size of 7–10 persons had 37.2 % IgM positive compared to 36.9 % IgM negative (OR = 1.68 95 % CI: 0.61–4.89); with an overall adjusted OR of 2.1 (95 % CI: 1.2–4.2). The seroprevalence of IgM did not differ significantly by other variables.
In multivariable analysis adjusting for sampling location, the odds of HCMV infection were nearly twice as high for females compared to males (OR = 1.89 95 % CI: 1.10–3.25). Increasing income on a log-transformed scale had lower odds of being positive for HCMV infection (OR = 0.72 95 % CI: 0.54–0.96). Increasing age on a log-transformed scale was associated with greater odds of seropositivity for HCMV (OR = 3.95 95 % CI: 1.79–8.71) (Table 2). Univariate analysis showed that “married” marital status was significantly associated (p = 0.008) with HCMV-IgG seroprevalence, which was not observed when we undertook multiple logistic regression analysis in the presence of increasing age and other variables.
In this study, we determined the seroprevalence of HCMV infection in adult populations of Pakistan. Our results reveal a high seroprevalence of HCMV infection, with an average of 93.2 % of individuals aged ≥ 18 years, showing the presence of HCMV-specific IgG antibodies indicative of persistent infection. This is consistent with studies reported from Asia, South America and the Caribbean [10, 12, 24] but higher than that reported from North America, Europe, Australia and Africa [7, 8, 15, 16, 25]. The IgM seroprevalence was 4.3 %, which is similar to a previously reported estimate  but higher than 0.9–3 % IgM seroprevalence in several other countries [11, 12, 27–30]. However, much greater variations in serum IgM seroprevalence (0–19.5 %) have been reported from developing countries [9, 31]. 95.3 % of individuals who were IgM seropositive were also seropositive for IgG. In the absence of either a confirmed sero-conversion or IgG avidity testing it was not possible to define what proportion of these cases represented primary infection or non-primary reactivation of IgM. Interestingly, a recent analysis of HCMV IgM seroprevalence in women of reproductive age in USA also found that 97.5 % of IgM seropositive women were CMV IgG seropositive . IgG avidity testing in countries with a high prevalence of HCMV infection, such as Korea and Turkey; have shown that none of the women with an IgM seropositive and IgG seropositive sero-status had evidence of a primary infection [33, 34]. As such, we would suggest that the great majority of IgM seropositive cases within our cohort represent viral recurrent reinfection or reactivation rather than primary infection.
Despite the general very high seroprevalence of HCMV infection, 6.6 % of the population remained seronegative. It is likely that good hygiene, hand washing and limited sharing of edibles and used utensils serve to limit infection rates in some populations . The low percentage of individuals with a HCMV-IgM positive and HCMV-IgG negative profile (0.2 %) indicates that the great majority of infections occur during childhood although our data also reveal a significant increase in seroprevalence of men between the ages of 25 and 34 years.
Significant differences apparent in relation to the seroprevalence of HCMV infection in different locations are likely to be attributed to the marked differences in socioeconomic status between the government and private hospital patient populations. In particular, a very high proportion of the patients visiting JPMC belong to the low socioeconomic strata of the society in whom HCMV-IgG seroprevalence reached 95 %.
When we compared the HCMV-IgG seropositivity between the different age groups, we observed a rise in HCMV-IgG seropositivity from age group ≤ 25 years to age group 35–45 years. However, this increase is not as high as has been observed in previous studies and reflects the high baseline prevalence of infection by the time of early adulthood [16, 36]. Nevertheless, our findings concur with other studies from areas of high seroprevalence where a positive HCMV-IgG response was observed in more than 90 % of the individuals in the age group 18 to 35 years [9, 12].
Gender differences in HCMV seroprevalence have been noted previously [7, 15, 16, 36]. In our study, younger adult males are shown to be much more vulnerable to a primary HCMV infection than females and seroprevalence within men increased by 12 % between the age groups ≤ 25 years and 35–45 years. Women can acquire primary infection through their own infected children’s urine and saliva . Therefore those women who remain HCMV seronegative as they enter early adulthood are more likely to be at risk of acquiring HCMV infection from their children than men at this stage. Importantly, nearly all women have had a primary HCMV infection as they reach childbearing age in contrast to developed countries where many women remain seronegative at reproductive age [15, 16, 25]. This is important in relation to the potential susceptibility to primary infection during pregnancy as this is associated with risk of congenital transmission. The seroprevalence of HCMV infection remained high in women of all ages and was still found in 96 % of those aged over 45 years. Interestingly, the seroprevalence of HCMV was slightly reduced in men aged > 45 years. Reasons for this age-related reduction are unclear. It is very unlikely that seroprevalence of HCMV was lower during early adulthood in the current group of individuals aged > 45 years. As such, it is possible that HCMV infection has been associated with excess mortality within males, such that the proportion of HCMV seronegative individuals may have increased slightly over time. Indeed, infection has regularly been correlated with a significant increase in mortality rates in older individuals and it is possible that this effect is more pronounced within male subjects in developing countries.
Previous studies examining the relation between HCMV seroprevalence and socioeconomic status in developing countries have examined small sample size compared to studies undertaken in developed countries [7, 18, 38]. By targeting a relatively large population, we were able to demonstrate an inverse relationship between socioeconomic status and HCMV-IgG seroprevalence, which is consistent with several previous reports [15, 17, 18, 36, 39]. However, in contrast to a previous study , household size does not seem to contribute to the disparity in persistent HCMV infection within our population. It has been suggested that people at the lower ends of the education and income spectrum are likely to spend longer time with HCMV infection , primarily due to more crowded living conditions . However the definitive reason for the increased seroprevalence of HCMV within poorer communities remains unclear.
Univariate analysis showed a significant association between ‘married’ marital status and HCMV IgG seroprevalence, which is reported to reflect increased viral exposure via vertical and horizontal modes of transmission [37, 41]. The prevalence of HCMV infection did not appear to be influenced by ethnicity in our population.
A unique feature of our study was an epidemiological assessment of sociodemographic factors in relation to IgM sero-status as this has not been widely studied previously. An important finding was that only two individuals were IgM seropositive but IgG seronegative, a pattern which implies recent primary infection. However, false positive HCMV IgM results due to interfering infections in IgG seronegative individuals may exist. As such, as discussed above, IgM sero-status is likely to reflect a humoral response to viral reinfection or reactivation [28, 42]. Indeed, HCMV infection is unusual in that IgM seropositivity can occur in individuals with persistent infection, whereas an IgM antibody response is generally observed only in the setting of acute infection for other pathogens. A striking observation was the increased seroprevalence of HCMV-IgM in association with decreasing household size. No association was seen between IgM and increasing crowding index and so increased frequency of HCMV transmission due to close contact with infected individuals is unlikely to be an explanation. Indeed our data may suggest an opposite explanation, in that smaller families are less likely, at any given time, to house an individual with primary infection. As such, it may be that the regular environmental exposure to HCMV in larger families serves to boost established HCMV-specific immunity and control endogenous viral replication. In this regard, individuals who do not get such regular environmental challenge may undergo more frequent episodes of endogenous viral replication, which would stimulate recurrent IgM immune responses. Interestingly, a recent study of IgM seroprevalence in US women observed a non-significant increase in prevalence within single women compared to married women (6.8 % vs 3.8 %) which could be compatible with this observation . Further epidemiological and virological studies will be required to investigate this observation further.
The two major strengths of this study included a large sample size (N = 1000) and first estimate for HCMV seroprevalence in diverse subgroups of population in a developing country. Our comprehensive analysis was based on a questionnaire which gathered data about living conditions and provided an insight into the reasons that could account for such a high seroprevalence of this virus in a developing country.
Congenital infection with HCMV is a significant cause of morbidity and mortality and several candidate HCMV vaccines are under investigation. However, the development of a vaccine programme must take into account the potential risk of increasing the proportion of women who remain HCMV seronegative as they enter pregnancy. Our findings reveal that up to 6 % of women of childbearing age remain HCMV seronegative in Pakistan, and the risk of primary infection within this group may be significant given our observation that around 0.5 % of men of a similar age may be undergoing primary infection each year, an event followed by prolonged viral secretion, which could serve to drive infection in the women who remain uninfected at this age.
Our study serves as a preliminary work towards improved understanding about the status of HCMV infection in Pakistan; mainly so because such a large number of participants with sociodemographic data has not been studied for the assessment of this particular virus.
Some limitations of the work include the study design and broad age categories, which prevented modeling of a definitive temporal relationship between age and HCMV seroprevalence.
In conclusion, this study suggests that the seroprevalence of HCMV infection varies considerably by gender, age, marital status and socioeconomic status in this setting in Pakistan. Despite the high overall prevalence of HCMV infection, around 6 % of women of childbearing age remained at risk of primary infection. Amongst those with persistent infection, people who live in smaller households are more likely to demonstrate IgM seropositivity. IgM production is likely to indicate a response to endogenous viral reactivation and suggests that the more frequent exposure to viral infection within larger household size may boost protective endogenous immunity.
More research is needed to study and understand the time trends in the epidemiology of HCMV infection among seronegative pregnant women and neonates in the high endemic population of Pakistan that would lead to the initiation of a potential HCMV prevention and vaccination programme when available.
Aga Khan University Hospital
Cytomegalic inclusion disease
Jinnah Postgraduate Medical Centre
Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22(1):76–98.
Landolfo S, Gariglio M, Gribaudo G, Lembo D. The human cytomegalovirus. Pharmacol Ther. 2003;98(3):269–97.
Harari A, Zimmerli SC, Pantaleo G. Cytomegalovirus (CMV)-specific cellular immune responses. Hum Immunol. 2004;65(5):500–6.
Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4(12):725–38.
Rowshani AT, Bemelman FJ, van Leeuwen EM, van Lier RA, ten Berge IJ. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation. 2005;79(4):381–6.
Hummel M, Abecassis MM. A model for reactivation of CMV from latency. J Clin Virol. 2002;25 Suppl 2:S123–36.
Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006;43(9):1143–51.
Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis. 2008;8:111.
Kothari A, Ramachandran VG, Gupta P, Singh B, Talwar V. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India. J Health Popul Nutr. 2002;20(4):348–51.
Fang FQ, Fan QS, Yang ZJ, Peng YB, Zhang L, Mao KZ, et al. Incidence of cytomegalovirus infection in Shanghai, China. Clin Vaccine Immunol. 2009;16(11):1700–3.
Tagawa M, Minematsu T, Masuzaki H, Ishimaru T, Moriuchi H. Seroepidemiological survey of cytomegalovirus infection among pregnant women in Nagasaki, Japan. Pediatr Int. 2010;52(3):459–62.
Souza MA, Passos AM, Treitinger A, Spada C. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil. Rev Soc Bras Med Trop. 2010;43(4):359–61.
Spano LC, Gatti J, Nascimento JP, Leite JP. Prevalence of human cytomegalovirus infection in pregnant and non-pregnant women. J Infect. 2004;48(3):213–20.
de Ory F, Ramirez R, Garcia Comas L, Leon P, Sagues MJ, Sanz JC. Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol. 2004;19(1):85–9.
Lubeck PR, Doerr HW, Rabenau HF. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol. 2010;199(1):53–60.
Lopo S, Vinagre E, Palminha P, Paixao MT, Nogueira P, Freitas MG. Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003. Euro Surveill. 2011;16(25):1–6.
Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect. 2009;137(1):58–65.
Zajacova A, Dowd JB, Aiello AE. Socioeconomic and race/ethnic patterns in persistent infection burden among U.S. adults. J Gerontol A Biol Sci Med Sci. 2009;64(2):272–9.
N’Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, et al. Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France. PLoS One. 2014;9(2):e89857.
Zhang Q, Gao Y, Peng Y, Fu M, Liu YQ, Zhou QJ, et al. Epidemiological survey of human cytomegalovirus antibody levels in children from Southeastern China. Virol J. 2014;11:123.
Rizvi CB, Raza A, Siddiqui MF, Alam R. Sero-prevalence of human cytomegalovirus among blood donors in Lahore, Pakistan. Adv Life Sci. 2015;2(4):171–5.
Official Web Portal of Karachi Metropolitan Corporation. http://www.karachicity.gov.pk/. Accessed 20 Jan 2016.
Centers for Disease Control and Prevention. In: Cytomegalovirus (CMV) and Congenital CMV Infection. http://www.cdc.gov/cmv/clinical/. Accessed 20 Jan 2016.
Correa CB, Kouri V, Verdasquera D, Martinez PA, Alvarez A, Aleman Y, et al. HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008. Prenat Diagn. 2010;30(9):888–92.
Seale H, MacIntyre CR, Gidding HF, Backhouse JL, Dwyer DE, Gilbert L. National serosurvey of cytomegalovirus in Australia. Clin Vaccine Immunol. 2006;13(11):1181–4.
Mustakangas P, Sarna S, Ammala P, Muttilainen M, Koskela P, Koskiniemi M. Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study. Int J Epidemiol. 2000;29(3):587–91.
De Paschale M, Agrappi C, Manco MT, Paganini A, Clerici P. Incidence and risk of cytomegalovirus infection during pregnancy in an urban area of Northern Italy. Infect Dis Obstet Gynecol. 2009;2009:206505.
Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol. 2011;18(11):1895–9.
Uyar Y, Balci A, Akcali A, Cabar C. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. New Microbiol. 2008;31(4):451–5.
Bagheri L, Mokhtarian H, Sarshar N, Ghahramani M. Seroepidemiology of cytomegalovirus infection during pregnancy in Gonabad, east of Iran: a cross-sectional study. J Res Health Sci. 2012;12(1):38–44.
Akinbami AA, Akanmu AS, Adeyemo TA, Wright KO, Dada MO, Dosunmu AO. Cytomegalovirus antibodies among healthy blood donors at Lagos University Teaching Hospital. S Afr Med J. 2009;99(7):528–30.
Wang C, Dollard SC, Amin MM, Bialek SR. Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States. PLoS One. 2016;11(3):e0151996.
Seo S, Cho Y, Park J. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test. Korean J Lab Med. 2009;29(6):557–62.
Uysal A, Taner CE, Cuce M, Atalay S, Gol B, Kose S, et al. Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir/Turkey: follow-up and results of pregnancy outcome. Arch Gynecol Obstet. 2012;286(3):605–8.
Revello MG, Tibaldi C, Masuelli G, Frisina V, Sacchi A, Furione M, et al. Prevention of Primary Cytomegalovirus Infection in Pregnancy. EBioMedicine. 2015;2(9):1205–10.
Zhao P, Ma D, Xue F, Ji C, Wang S, Zhang X, et al. Seroprevalence and risk factors of human cytomegalovirus infection in the eastern Chinese population. Arch Virol. 2009;154(4):561–4.
Revello MG, Campanini G, Piralla A, Furione M, Percivalle E, Zavattoni M, et al. Molecular epidemiology of primary human cytomegalovirus infection in pregnant women and their families. J Med Virol. 2008;80(8):1415–25.
Sheevani JN, Aggarwal A. A pilot seroepidemiological study of cytomegalovirus infection in women of child bearing age. Indian J Med Microbiol. 2005;23(1):34–6.
Colugnati FA, Staras SA, Dollard SC, Cannon MJ. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis. 2007;7:71.
Lanzieri TM, Dollard SC, Bialek SR, Grosse SD. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014;22:44–8.
Bodurtha J, Adler SP, Nance WE. Seroepidemiology of cytomegalovirus and herpes simplex virus in twins and their families. Am J Epidemiol. 1988;128(2):268–76.
Pass RF, Griffiths PD, August AM. Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Infect Dis. 1983;147(1):40–6.
We thank Dr. Saeed Hamid (Department of Medicine, The Aga Khan University, Karachi, Pakistan) and Dr. Romaina Iqbal (Department of Community Health Sciences, The Aga Khan University, Karachi, Pakistan) and their team for their help in sample and data collection. We also thank the phlebotomy staff at JPMC for their help in blood collection.
This study was supported by the British Council INSPIRE programme through a partnership grant (RCS Ref 09-0774), The Aga Khan University and generous donors. The funding body had no role in the design of the study and collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the article for publication.
Availability of data and materials
To protect the privacy of participants, dataset is not openly available. Data will be shared upon reasonable request and it is subjected to the data protection regulations.
SI carried out data collection, experiments, statistical analysis, and interpretation of data and drafted the manuscript. AAS coordinated and supervised the study and critically reviewed the manuscript. ARS designed and planned the study, participated in questionnaire development, and performed statistical analysis, interpretation of data and critical revision of the manuscript. WA coordinated the study, supervised data collection and critically reviewed the manuscript. PAHM and ENL conceived of the study, participated in the design of the study, supervised the study, interpretation of the data and critically reviewed the data and manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
The study was approved by the Ethical Review Committee of AKU and Institutional Review Board Committee of JPMC. Written informed consent was obtained from each of the participants studied.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Ibrahim, S., Siddiqui, A.A., Siddiqui, A.R. et al. Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey. BMC Public Health 16, 1112 (2016). https://doi.org/10.1186/s12889-016-3772-8
- Human cytomegalovirus
- Sociodemographic factors